GlaxoSmithKline Turkey

GSK Türkiye presents itself as part of a biopharma company that brings together science, technology and talent to prevent disease. It states that it discovers, develops and works to make medicines and vaccines accessible to patients and stakeholders, with the aim of positively impacting the health of 2.5 billion people by the end of 2030. Its R&D focus is described across four therapeutic areas: Respiratory/Immunology and Inflammation, Oncology, HIV, and Infectious diseases. The site also references company life, social responsibility projects and press releases, including a March 6, 2025 item about GSK Türkiye and TOG expanding work at the Adıyaman Support Center.

GSK Türkiye describes itself as part of a biopharma company that brings together science, technology and talent to prevent disease. It states that, as a biopharma-focused company, it discovers, develops and works to make medicines and vaccines accessible to patients and stakeholders, aiming to positively impact the health of 2.5 billion people by the end of 2030. Its R&D focus is described across four therapeutic areas: Respiratory/Immunology and Inflammation, Oncology, HIV, and Infectious diseases. The site also highlights company life, social responsibility projects and press releases, including a March 6, 2025 item about GSK Türkiye and TOG expanding work at the Adıyaman Support Center.

Biopharma company focused on science, technology and talent to prevent disease, with R&D across four therapeutic areas.

1. 1Anasayfa | GSK Türkiyetr.gsk.com
2. 2GlaxoSmithKline Turkeywikidata.org